Compare LNTH & VNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LNTH | VNO |
|---|---|---|
| Founded | 1956 | 1946 |
| Country | United States | United States |
| Employees | N/A | 3145 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 6.3B |
| IPO Year | 2014 | N/A |
| Metric | LNTH | VNO |
|---|---|---|
| Price | $108.28 | $37.89 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 10 |
| Target Price | ★ $87.00 | $33.00 |
| AVG Volume (30 Days) | 876.2K | ★ 1.8M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 2.52% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.80 | N/A |
| Revenue | ★ $343,374,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $14.19 | $5.42 |
| P/E Ratio | $58.31 | ★ $7.08 |
| Revenue Growth | ★ 3.62 | N/A |
| 52 Week Low | $47.27 | $24.57 |
| 52 Week High | $107.99 | $43.37 |
| Indicator | LNTH | VNO |
|---|---|---|
| Relative Strength Index (RSI) | 69.40 | 65.14 |
| Support Level | $95.00 | $33.23 |
| Resistance Level | N/A | $39.62 |
| Average True Range (ATR) | 3.04 | 1.10 |
| MACD | -0.05 | -0.15 |
| Stochastic Oscillator | 94.61 | 71.40 |
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Vornado Realty Trust is a fully integrated real estate investment trust with a portfolio of New York City office, retail, and multifamily assets, and the developer of the new Penn District. While concentrated in New York, the trust also owns assets in both Chicago and San Francisco. It generates revenue in the form of property rentals, fees charged for trade shows, parking revenues, management and leasing fees, etc. Vornado operates in the following reportable segments: New York (its key revenue-generating market) and Other.